NANOPHASE TECHNOLOGIES CORPORATION 4
4 · NANOPHASE TECHNOLOGIES CORPORATION · Filed Jul 2, 2007
Insider Transaction Report
Form 4
PERKINS DONALD S
Director
Transactions
- Award
Deferred Common Stock
2007-07-02+979→ 6,752 total→ Common Stock (979 underlying)
Holdings
- 20,000
Stock Option (right to buy)
Exercise: $3.50From: 1999-10-29Exp: 2008-10-29→ Common Stock (25,000 underlying) - 3,334
Stock Option (right to buy)
Exercise: $5.75From: 1999-02-19Exp: 2008-02-19→ Common Stock (10,000 underlying) - 42,144
Common Stock
- 667
Stock Option (right to buy)
Exercise: $5.25From: 1999-06-10Exp: 2008-06-10→ Common Stock (2,000 underlying) - 6,667
Stock Option (right to buy)
Exercise: $1.75From: 2000-07-27Exp: 2009-07-27→ Common Stock (10,000 underlying) - 2,000
Stock Option (right to buy)
Exercise: $9.92From: 2002-06-05Exp: 2011-06-05→ Common Stock (2,000 underlying)
Footnotes (6)
- [F1]Subject to certain restrictions, beginning on this date, options vest in five equal installments.
- [F2]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
- [F3]Each share of deferred common stock represents a right to receive one share of common stock.
- [F4]979 shares of common stock were to be granted under the Company's 2005 Non-Employee Director Restricted Stock Plan. Such shares are vested immediately but subject to certain transfer restrictions. Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive instead 979 shares of deferred common stock which, along with the 5,773 similar shares granted previously, will be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
- [F5]The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
- [F6]Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive 979 shares of deferred common stock, amounting to a cumulative total of 6,752 shares of deferred common stock received (including those received from previous grants) to date, which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.